tiprankstipranks
Bridgebio Pharma (BBIO)
:BBIO
US Market

BridgeBio Pharma (BBIO) Technical Analysis

Compare
1,162 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
4Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bridgebio Pharma’s (BBIO) Moving Averages Convergence Divergence (MACD) indicator is 0.71, suggesting Bridgebio Pharma is a Sell.
Bridgebio Pharma’s (BBIO) 20-Day exponential moving average is 34.44, while Bridgebio Pharma’s (BBIO) share price is $36.4, making it a Buy.
Bridgebio Pharma’s (BBIO) 50-Day exponential moving average is 33.31, while Bridgebio Pharma’s (BBIO) share price is $36.4, making it a Buy.

BridgeBio Pharma (BBIO) Pivot Points

Mar 29, 2025, 10:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
34.56
35.17
35.63
36.24
36.70
37.31
37.77
Fibonacci
35.17
35.58
35.83
36.24
36.65
36.90
37.31
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BridgeBio Pharma (BBIO) Moving Averages

Mar 29, 2025, 10:39 AM
Period
Simple
Exponential
MA5
36.25Buy
35.95Buy
MA10
34.71Buy
35.14Buy
MA20
33.80Buy
34.44Buy
MA50
34.24Buy
33.31Buy
MA100
30.58Buy
31.53Buy
MA200
28.29Buy
29.58Buy
Bridgebio Pharma’s (BBIO) 10-Day exponential moving average is 35.14, while Bridgebio Pharma’s (BBIO) share price is $36.4, making it a Buy.
Bridgebio Pharma’s (BBIO) 100-Day exponential moving average is 31.53, while Bridgebio Pharma’s (BBIO) share price is $36.4, making it a Buy.
Bridgebio Pharma’s (BBIO) stock price is $36.4 and Bridgebio Pharma’s (BBIO) 50-day simple moving average is 34.24, creating a Buy signal.
Bridgebio Pharma’s (BBIO) stock price is $36.4 and Bridgebio Pharma’s (BBIO) 100-day simple moving average is 30.58, creating a Buy signal.
Bridgebio Pharma’s (BBIO) stock price is $36.4 and Bridgebio Pharma’s (BBIO) 200-day simple moving average is 28.29, creating a Buy signal.

BridgeBio Pharma (BBIO) Technical Indicators

Mar 29, 2025, 10:39 AM
Name
Value
Implied Action
RSI (14)
60.01
Neutral
STOCH (9,6)
76.29
Neutral
STOCHRSI (14)
79.36
Neutral
MACD (12,26)
0.71
Sell
ADX (14)
16.22
Buy
Williams %R
-20.82
Buy
CCI (14)
133.66
Sell
ATR (14)
1.66
-
Ultimate Oscillator
62.63
Neutral
ROC
15.30
Buy
Bridgebio Pharma’s (BBIO) Relative Strength Index (RSI) is 60.01, creating a Neutral signal.
Bridgebio Pharma’s (BBIO) Trend Strength Indicator (ADX) is 16.22, creating a Buy signal.
Bridgebio Pharma’s (BBIO) Commodity Channel Index (CCI) is 133.66, creating a Sell signal.
Bridgebio Pharma’s (BBIO) Price Rate of Change (ROC) is 15.30, creating a Buy signal.

FAQ

Is BBIO a Buy, Hold, or Sell?
Based on BBIO’s technical indicators, BBIO is a Strong Buy.
    What is BBIO’s RSI (14)?
    BBIO’s RSI (14) is 60.01, which suggests BBIO is a Neutral.
      What is BBIO’s MACD?
      BBIO’s MACD is 0.71, which suggests BBIO is a Sell.
        What is BBIO’s 5-day moving average?
        BBIO’s 5-day moving average is 36.25, which suggests BBIO is a Buy.
          What is BBIO’s 20-day moving average?
          BBIO 20-day moving average is 33.80, which suggests BBIO is a Buy.
            What is BBIO’s 50-day moving average?
            BBIO’s 50-day moving average is 34.24, which suggests BBIO is a Buy.
              What is BBIO’s 200-day moving average?
              BBIO’s 200-day moving average is 28.29, which suggests BBIO is a Buy.
                What is BBIO’s Williams % R (14)?
                BBIO’s Williams % R (14) is -20.82, which suggests BBIO is a Buy.
                  What is BBIO’s CCI (14)?
                  BBIO’s CCI (14) is 133.66, which suggests BBIO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis